SARAH HARTMAN: Open Payments
NPI 1073823670 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 26 payments from 8 companies in 2025. Trend: 2023 $875 · 2024 $1,369 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $188 |
| Galderma Laboratories, L.P. | 1 | $150 |
| Amgen Inc. | 3 | $69 |
| ABBVIE INC. | 4 | $68 |
| Lilly USA, LLC | 2 | $36 |
| Incyte Corporation | 1 | $21 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: TREMFYA, NEMLUVIO, Otezla, SKYRIZI, TALTZ, OPZELURA, Winlevi, COSENTYX.
Industry payments across PA — which companies pay providers there.
